Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study
Grube E, Van Mieghem NM, Bleiziffer S, Modine T, Bosmans J, Manoharan G, Linke A, Scholtz W, Tch»tch» D, Finkelstein A, Trillo R, Fiorina C, Walton A, Malkin CJ, Oh JK, Qiao H, Windecker S; FORWARD Study Investigators
(2017), J Am Coll Cardiol, 70(7), 845-53
Association of neighborhood demographics with out-of-hospital cardiac arrest treatment and outcomes: where you live may matter
Starks MA, Schmicker RH, Peterson ED, May S, Buick JE, Kudenchuk PJ, Drennan IR, Herren H, Jasti J, Sayre M, Stub D, Vilke GM, Stephens SW, Chang AM, Nuttall J, Nichol G; Resuscitation Outcomes Consortium (ROC)
(2017), JAMA Cardiol, 2(10), 1110-8
Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience
Perlman GY, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman MA, LeBlanc H, Buller CE, Rod»s-Cabau J, Webb JG
(2017), EuroIntervention, 12(13), 1653-9
The barriers associated with emergency medical service use for acute coronary syndrome: the awareness and influence of an Australian public mass media campaign
Cartledge S, Finn J, Straney L, Ngu P, Stub D, Patsamanis H, Shaw J, Bray J
(2017), Emerg Med J, 34(7), 466-71
Trends and Impact of Door-to-Balloon Time on Clinical Outcomes in Patients Aged <75, 75 to 84, and ?85 Years With ST-Elevation Myocardial Infarction
Yudi MB, Hamilton G, Farouque O, Andrianopoulos N, Duffy SJ, Lefkovits J, Brennan A, Fernando D, Hiew C, Freeman M, Reid CM, Dakis R, Ajani AE, Clark DJ; Melbourne Interventional Group
(2017), Am J Cardiol, 120(8), 1245-53
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
Yeoh J, Yudi MB, Andrianopoulos N, Yan BP, Clark DJ, Duffy SJ, Brennan A, New G, Freeman M, Eccleston D, Sebastian M, Reid CM, Wilson W, Ajani AE; Melbourne Interventional Group
(2017), Am J Cardiol, 120(1), 47-54
The prognostic significance of smoking cessation after acute coronary syndromes: an observational, multicentre study from the Melbourne interventional group registry
Yudi MB, Farouque O, Andrianopoulos N, Ajani AE, Kalten K, Brennan AL, Lefkovits J, Hiew C, Oqueli E, Reid CM, Duffy SJ, Clark DJ; Melbourne Interventional Group
(2017), BMJ Open, 7(10), e016874
SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T
Costello BT, Springer F, Hare JL, Gerche A, Iles L, Ellims AH, Schmitt B, Taylor AJ
(2017), Int J Cardiovasc Imaging, 33(10), 1551-60
A clinical perspective of anti-fibrotic therapies for cardiovascular disease
Fang L, Murphy AJ, Dart AM
(2017), Front Pharmacol, 8, 186
Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy
Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A, Dart AM
(2017), Am J Transl Res, 9(11), 5063-73
Caudal fluoroscopy to guide venous access for pacemaker device implantation: should this now be standard practice?
Patel HC, Hayward C, Nanayakkara S, Broughton A, Mariani JA
(2017), Heart Asia, 9(1), 68-9
Cardiac implantable electronic device hematomas: risk factors and effect of prophylactic pressure bandaging
Koh Y, Bingham NE, Law N, Le D, Mariani JA
(2017), Pacing Clin Electrophysiol, 40(7), 857-67
DOI: 10.1111/pace.13106
Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat
Tate M, Deo M, Cao AH, Hood SG, Huynh K, Kiriazis H, Du XJ, Julius TL, Figtree GA, Dusting GJ, Kaye DM, Ritchie RH
(2017), Diab Vasc Dis Res, 14(5), 423-33
N-Acetylcysteine attenuates the development of renal fibrosis in transgenic mice with dilated cardiomyopathy
Giam B, Kuruppu S, Chu PY, Smith AI, Marques FZ, Fiedler A, Horlock D, Kiriazis H, Du XJ, Kaye DM, Rajapakse NW
(2017), Sci Rep, 7, 17718
Impaired right heart and pulmonary vascular function in HFpEF: time for more risk markers?
Kaye DM, Marwick TH
(2017), JACC Cardiovasc Imaging, 10(10 Pt B), 1222-4
Understanding the role of the LA in functional responses to heart failure
Marwick TH, Kaye D
(2017), JACC Cardiovasc Imaging, 10(10 Pt B), 1265-7
The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy
De Blasio MJ, Ramalingam A, Cao AH, Prakoso D, Ye JM, Pickering R, Watson AMD, de Haan JB, Kaye DM, Ritchie RH
(2017), Eur J Pharmacol, 807, 12-20
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Qin CX, May LT, Li R, Cao N, Rosli S, Deo M, Alexander AE, Horlock D, Bourke JE, Yang YH, Stewart AG, Kaye DM, Du XJ, Sexton PM, Christopoulos A, Gao XM, Ritchie RH
(2017), Nat Commun, 8, 14232
DOI: 10.1038/ncomms14232
High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice
Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, Mackay CR, Kaye DM
(2017), Circulation, 135(10), 964-77
Cardiac gene delivery using recirculating devices
Byrne MJ, Kaye DM
(2017), In: Ishikawa K (ed), Methods in Molecular Biology, volume 1521, Cardiac Gene Therapy: Methods and Protocols, Springer, Chapter 19, 261-9